In a filing, Immunome Inc revealed its Director BIENAIME JEAN JACQUES acquired Company’s shares for reported $97608.0 on Aug 16 ’24. In the deal valued at $13.94 per share,7,000 shares were bought. As a result of this transaction, BIENAIME JEAN JACQUES now holds 16,615 shares worth roughly $0.25 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Higgins Jack sold 3,524 shares, generating $49,072 in total proceeds. Upon selling the shares at $13.93, the Chief Scientific Officer now owns 16,000 shares.
Before that, Higgins Jack bought 3,524 shares. Immunome Inc shares valued at $49,073 were divested by the Officer at a price of $13.93 per share.
Piper Sandler initiated its Immunome Inc [IMNM] rating to an Overweight in a research note published on May 31, 2024; the price target was $27. A number of analysts have revised their coverage, including JP Morgan’s analysts, who began to cover the stock in late April with a ‘”an Overweight”‘ rating. Guggenheim began covering IMNM with “Buy” recommendation on April 15, 2024. Leerink Partners started covering the stock on January 29, 2024. It rated IMNM as “an Outperform”.
Price Performance Review of IMNM
On Friday, Immunome Inc [NASDAQ:IMNM] saw its stock fall -0.39% to $15.18. Over the last five days, the stock has lost -1.75%. Immunome Inc shares have risen nearly 41.87% since the year began. Nevertheless, the stocks have risen 142.11% over the past one year. While a 52-week high of $30.96 was reached on 03/07/24, a 52-week low of $6.13 was recorded on 01/02/24. SMA at 50 days reached $13.75, while 200 days put it at $15.50.
Levels Of Support And Resistance For IMNM Stock
The 24-hour chart illustrates a support level at 14.81, which if violated will result in even more drops to 14.44. On the upside, there is a resistance level at 15.62. A further resistance level may holdings at 16.06. The Relative Strength Index (RSI) on the 14-day chart is 55.36, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.61, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 28.98%. Stochastics %K at 78.08% indicates the stock is a holding.
How much short interest is there in Immunome Inc?
A steep rise in short interest was recorded in Immunome Inc stocks on 2024-08-15, dropping by -0.92 million shares to a total of 12.55 million shares. Yahoo Finance data shows the prior-month short interest on 2024-07-15 was 13.46 million shares. There was a decline of -7.3%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on December 19, 2023 when Wedbush began covering the stock and recommended ‘”an Outperform”‘ rating along with a $12 price target.
